Australia's largest stock trading and investment forum Australia's #1 stock forum

MPA

Click for more information

1.54%

6.6¢ mad paws holdings limited

IPO - Mad Paws Holdings Limited - 26 March 2021 #, page-37

First 37 Last

Share
Profile

Follow
Hornacek

57 Posts.

3

31/03/21

13:24

Post #: 52172212
Share

Originally posted by jr189: ↑

Have read the prospectus, not much I like about this business. It is very niche and the metrics don't inspire any interest. It is sub scale and and certainly does not deserve a 7x revenue multiple as they are proposing.

GMV grew
FY18 - FY19 by $3,099,466 then;
FY19 - FY20 by $1,546,780
That is not good at all, that should be accelerating not decreasing for a *growth* business.

Revenue follows the same
FY18 - FY19 by $690,000 then
FY19 - FY20 by $420,963

If you divide their marketing spend by the increase in new paying customers, works out at a CAC of ~$70-83. Ouch!

If you divide their number of paying customers by the yearly revenue it is $28 revenue per paying customer, so a ~2.5-3 year return on the CAC alone (before CoGs like payment costs, customer service etc)

If you look at that GMV growth in FY20 of $1,546,780 they had to spend almost the same in marketing $1,423,386 to get that and that is GMV not revenue !

Niche business, no forecasts, low quality brokers, negative absolute growth and high valuation. Good luck to all but a pass for me.

Expand

very high CaC, puts pressure on ensuring the company maintains the customer for a particular length to get ROI. Tough gig.

MPA Price at posting: 19.5¢ Sentiment: None Disclosure: Not Held
2 Upvote

0 Great analysis

Reply

Top Stories

NYR

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

NEU

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

CHM

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

There are more pages in this discussion • 7 more messages in this thread...

First 37 Last

Add MPA (ASX) to my watchlist

(20min delay)
Last 6.6¢		Change 0.001(1.54%)		Mkt cap ! $26.81M

Open	High	Low	Value	Volume
6.6¢	6.6¢	6.6¢	$1.531K	23.29K

Buyers (Bids)

No.	Vol.	Price($)
1	6147	6.5¢

Sellers (Offers)

Price($)	Vol.	No.
6.6¢	31341	1

View Market Depth

No.	Vol.	Price($)
1	6147	0.065
1	15625	0.064
1	51000	0.063
2	200001	0.060
1	10000	0.040

Price($)	Vol.	No.
0.066	31341	1
0.067	39822	1
0.069	127886	2
0.070	130303	3
0.071	113358	2

Last trade - 16.10pm 07/10/2024 (20 minute delay)

MPA (ASX) Chart